-
1
-
-
20944434994
-
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
DOI 10.1164/rccm.200404-571OC
-
A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, K. Nakata, Y. Taguchi, S. Nagai, H. Itoh, M. Ohi, A. Sato, and S. Kudoh Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 171 2005 1040 1047 (Pubitemid 40616955)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.171
, Issue.9
, pp. 1040-1047
-
-
Azuma, A.1
Nukiwa, T.2
Tsuboi, E.3
Suga, M.4
Abe, S.5
Nakata, K.6
Taguchi, Y.7
Nagai, S.8
Itoh, H.9
Ohi, M.10
Sato, A.11
Kudoh, S.12
Raghu, G.13
-
2
-
-
33845365039
-
Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started
-
A. Benigni, C. Zoja, M. Campana, D. Corna, F. Sangalli, D. Rottoli, E. Gagliardini, S. Conti, S. Ledbetter, and G. Remuzzi Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started Nephron. Exp. Nephrol. 104 2006 e158 e168
-
(2006)
Nephron. Exp. Nephrol.
, vol.104
-
-
Benigni, A.1
Zoja, C.2
Campana, M.3
Corna, D.4
Sangalli, F.5
Rottoli, D.6
Gagliardini, E.7
Conti, S.8
Ledbetter, S.9
Remuzzi, G.10
-
3
-
-
16244422029
-
The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model
-
DOI 10.1016/j.transproceed.2004.12.150
-
N.R. Brook, J.R. Waller, G.R. Bicknell, and M.L. Nicholson The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model Transplant Proc. 37 2005 130 133 (Pubitemid 40459713)
-
(2005)
Transplantation Proceedings
, vol.37
, Issue.1
, pp. 130-133
-
-
Brook, N.R.1
Waller, J.R.2
Bicknell, G.R.3
Nicholson, M.L.4
-
4
-
-
0031771673
-
Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone
-
DOI 10.1016/S0192-0561(98)00042-3, PII S0192056198000423
-
W.C. Cain, R.W. Stuart, D.L. Lefkowitz, J.D. Starnes, S. Margolin, and S.S. Lefkowitz Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone Int. J. Immunopharmacol. 20 1998 685 695 (Pubitemid 28540774)
-
(1998)
International Journal of Immunopharmacology
, vol.20
, Issue.12
, pp. 685-695
-
-
Cain, W.C.1
Stuart, R.W.2
Lefkowitz, D.L.3
Starnes, J.D.4
Margolin, S.5
Lefkowitz, S.S.6
-
5
-
-
34548834734
-
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis
-
M.E. Cho, D.C. Smith, M.H. Branton, S.R. Penzak, and J.B. Kopp Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis Clin. J. Am. Soc. Nephrol. 2 2007 906 913
-
(2007)
Clin. J. Am. Soc. Nephrol.
, vol.2
, pp. 906-913
-
-
Cho, M.E.1
Smith, D.C.2
Branton, M.H.3
Penzak, S.R.4
Kopp, J.B.5
-
6
-
-
84876399666
-
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
-
V. Cottin The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis Respir. Res. 14 1 2013 S5
-
(2013)
Respir. Res.
, vol.14
, Issue.1
, pp. 5
-
-
Cottin, V.1
-
7
-
-
84863281562
-
Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis
-
C.N. D'Alessandro-Gabazza, T. Kobayashi, D. Boveda-Ruiz, T. Takagi, M. Toda, P. Gil-Bernabe, Y. Miyake, A. Yasukawa, Y. Matsuda, N. Suzuki, H. Saito, Y. Yano, A. Fukuda, T. Hasegawa, H. Toyobuku, S.I. Rennard, P.D. Wagner, J. Morser, Y. Takei, O. Taguchi, and E.C. Gabazza Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis Am. J. Respir. Cell Mol. Biol. 46 2012 397 406
-
(2012)
Am. J. Respir. Cell Mol. Biol.
, vol.46
, pp. 397-406
-
-
D'Alessandro-Gabazza, C.N.1
Kobayashi, T.2
Boveda-Ruiz, D.3
Takagi, T.4
Toda, M.5
Gil-Bernabe, P.6
Miyake, Y.7
Yasukawa, A.8
Matsuda, Y.9
Suzuki, N.10
Saito, H.11
Yano, Y.12
Fukuda, A.13
Hasegawa, T.14
Toyobuku, H.15
Rennard, S.I.16
Wagner, P.D.17
Morser, J.18
Takei, Y.19
Taguchi, O.20
Gabazza, E.C.21
more..
-
8
-
-
0033638127
-
Molecular basis of renal fibrosis
-
A.A. Eddy Molecular basis of renal fibrosis Pediatr. Nephrol. 15 2000 290 301
-
(2000)
Pediatr. Nephrol.
, vol.15
, pp. 290-301
-
-
Eddy, A.A.1
-
9
-
-
25444441069
-
Progression in chronic kidney disease
-
DOI 10.1053/j.ackd.2005.07.011, PII S1548559505001242, Pediatric Chronic Kidney Disease
-
A.A. Eddy Progression in chronic kidney disease Adv. Chronic Kidney Dis. 12 2005 353 365 (Pubitemid 41376493)
-
(2005)
Advances in Chronic Kidney Disease
, vol.12
, Issue.4
, pp. 353-365
-
-
Eddy, A.A.1
-
10
-
-
0032814167
-
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: Implications for the pathogenesis of tubulointerstitial fibrosis
-
R.E. Gilbert, L.L. Wu, D.J. Kelly, A. Cox, J.L. Wilkinson-Berka, C.I. Johnston, and M.E. Cooper Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis Am. J. Pathol. 155 1999 429 440 (Pubitemid 29370393)
-
(1999)
American Journal of Pathology
, vol.155
, Issue.2
, pp. 429-440
-
-
Gilbert, R.E.1
Wu, L.L.2
Kelly, D.J.3
Cox, A.4
Wilkinson-Berka, J.L.5
Johnston, C.I.6
Cooper, M.E.7
-
11
-
-
84857243208
-
Cell biology and pathology of podocytes
-
A. Greka, and P. Mundel Cell biology and pathology of podocytes Annu. Rev. Physiol. 74 2012 299 323
-
(2012)
Annu. Rev. Physiol.
, vol.74
, pp. 299-323
-
-
Greka, A.1
Mundel, P.2
-
12
-
-
84880141342
-
Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model
-
Q. Guan, S. Li, S. Gao, H. Chen, C.Y. Nguan, and C. Du Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model Am. J. Physiol. Renal Physiol. 305 2013 F199 F207
-
(2013)
Am. J. Physiol. Renal Physiol.
, vol.305
-
-
Guan, Q.1
Li, S.2
Gao, S.3
Chen, H.4
Nguan, C.Y.5
Du, C.6
-
14
-
-
84862201665
-
Pirfenidone inhibits TGF-β1-induced over-expression of collagen type i and heat shock protein 47 in A549 cells
-
K. Hisatomi, H. Mukae, N. Sakamoto, Y. Ishimatsu, T. Kakugawa, S. Hara, H. Fujita, S. Nakamichi, H. Oku, Y. Urata, H. Kubota, K. Nagata, and S. Kohno Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells BMC Pulm. Med. 12 2012 24
-
(2012)
BMC Pulm. Med.
, vol.12
, pp. 24
-
-
Hisatomi, K.1
Mukae, H.2
Sakamoto, N.3
Ishimatsu, Y.4
Kakugawa, T.5
Hara, S.6
Fujita, H.7
Nakamichi, S.8
Oku, H.9
Urata, Y.10
Kubota, H.11
Nagata, K.12
Kohno, S.13
-
15
-
-
0029318974
-
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
-
S.N. Iyer, J.S. Wild, M.J. Schiedt, D.M. Hyde, S.B. Margolin, and S.N. Giri Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters J. Lab. Clin. Med. 125 1995 779 785
-
(1995)
J. Lab. Clin. Med.
, vol.125
, pp. 779-785
-
-
Iyer, S.N.1
Wild, J.S.2
Schiedt, M.J.3
Hyde, D.M.4
Margolin, S.B.5
Giri, S.N.6
-
16
-
-
0032842405
-
Effects of pirfenidone on transforming growth factor-β gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
-
S.N. Iyer, G. Gurujeyalakshmi, and S.N. Giri Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis J. Pharmacol. Exp. Ther. 291 1999 367 373 (Pubitemid 29451612)
-
(1999)
Journal of Pharmacology and Experimental Therapeutics
, vol.291
, Issue.1
, pp. 367-373
-
-
Iyer, S.N.1
Gurujeyalakshmi, G.2
Giri, S.N.3
-
17
-
-
84884315497
-
KDIGO clinical practice guideline for glomerulonephritis
-
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group KDIGO clinical practice guideline for glomerulonephritis Kidney Int. Suppl. 2 2012 139 274
-
(2012)
Kidney Int. Suppl.
, vol.2
, pp. 139-274
-
-
-
18
-
-
84859442422
-
Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease
-
H.S. Lee Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease Cell Tissue Res. 347 2012 129 140
-
(2012)
Cell Tissue Res.
, vol.347
, pp. 129-140
-
-
Lee, H.S.1
-
19
-
-
13444271063
-
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats
-
DOI 10.1093/ndt/gfh562
-
S. Leh, ∅. Vaagnes, S.B. Margolin, B.M. Iversen, and T. Forslund Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats Nephrol. Dial. Transplant 20 2005 71 82 (Pubitemid 40207610)
-
(2005)
Nephrology Dialysis Transplantation
, vol.20
, Issue.1
, pp. 71-82
-
-
Leh, S.1
Vaagnes, O.2
Margolin, S.B.3
Iversen, B.M.4
Forslund, T.5
-
20
-
-
42149155557
-
Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis
-
A. Lewis, R. Steadman, P. Manley, K. Craig, C. de la Motte, V. Hascall, and A.O. Phillips Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis Histol. Histopathol. 23 2008 731 739 (Pubitemid 351552358)
-
(2008)
Histology and Histopathology
, vol.23
, Issue.4-6
, pp. 731-739
-
-
Lewis, A.1
Steadman, R.2
Manley, P.3
Craig, K.4
De La Motte, C.5
Hascall, V.6
Phillips, A.O.7
-
21
-
-
84455208254
-
The podocyte as a target for therapies - New and old
-
P.W. Mathieson The podocyte as a target for therapies - new and old Nat. Rev. Nephrol. 8 2011 52 56
-
(2011)
Nat. Rev. Nephrol.
, vol.8
, pp. 52-56
-
-
Mathieson, P.W.1
-
22
-
-
39049119220
-
Activation of the renin-angiotensin system and chronic hypoxia of the kidney
-
DOI 10.1291/hypres.31.175
-
M. Nangaku, and T. Fujita Activation of the renin-angiotensin system and chronic hypoxia of the kidney Hypertens. Res. 31 2008 175 184 (Pubitemid 351461095)
-
(2008)
Hypertension Research
, vol.31
, Issue.2
, pp. 175-184
-
-
Nangaku, M.1
Fujita, T.2
-
23
-
-
0020365813
-
Glomerular antigens in glomerulonephritis
-
DOI 10.1007/BF01892087
-
T.J. Neale, and C.B. Wilson Glomerular antigens in glomerulonephritis Springer Semin. Immunopathol. 5 1982 221 249 (Pubitemid 13178362)
-
(1982)
Springer Seminars in Immunopathology
, vol.5
, Issue.3
, pp. 221-249
-
-
Neale, T.J.1
Wilson, C.B.2
-
24
-
-
4644253515
-
Prevention of progressive fibrosis in chronic renal diseases: Antifibrotic agents
-
A.L. Negri Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents J. Nephrol. 17 2004 496 503 (Pubitemid 39302876)
-
(2004)
Journal of Nephrology
, vol.17
, Issue.4
, pp. 496-503
-
-
Negri, A.L.1
-
25
-
-
0029687126
-
Possible mechanisms of renal fibrosis
-
H. Okada, F. Strutz, T.M. Danoff, R. Kalluri, and E.G. Neilson Possible mechanisms of renal fibrosis Contrib. Nephrol. 118 1996 147 154
-
(1996)
Contrib. Nephrol.
, vol.118
, pp. 147-154
-
-
Okada, H.1
Strutz, F.2
Danoff, T.M.3
Kalluri, R.4
Neilson, E.G.5
-
26
-
-
48149113955
-
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
-
H. Oku, T. Shimizu, T. Kawabata, M. Nagira, I. Hikita, A. Ueyama, S. Matsushima, M. Torii, and A. Arimura Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis Eur. J. Pharmacol. 590 2008 400 408
-
(2008)
Eur. J. Pharmacol.
, vol.590
, pp. 400-408
-
-
Oku, H.1
Shimizu, T.2
Kawabata, T.3
Nagira, M.4
Hikita, I.5
Ueyama, A.6
Matsushima, S.7
Torii, M.8
Arimura, A.9
-
27
-
-
68149178848
-
Pirfenidone is renoprotective in diabetic kidney disease
-
S.P. RamachandraRao, Y. Zhu, T. Ravasi, T.A. McGowan, I. Toh, S.R. Dunn, S. Okada, M.A. Shaw, and K. Sharma Pirfenidone is renoprotective in diabetic kidney disease J. Am. Soc. Nephrol. 20 2009 1765 1775
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 1765-1775
-
-
Ramachandrarao, S.P.1
Zhu, Y.2
Ravasi, T.3
McGowan, T.A.4
Toh, I.5
Dunn, S.R.6
Okada, S.7
Shaw, M.A.8
Sharma, K.9
-
28
-
-
0031834709
-
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
-
DOI 10.1046/j.1523-1755.1998.00962.x
-
T. Shimizu, T. Kuroda, S. Hata, M. Fukagawa, S.B. Margolin, and K. Kurokawa Pirfenidone improves renal function and fibrosis in the post-obstructed kidney Kidney Int. 54 1998 99 109 (Pubitemid 28288024)
-
(1998)
Kidney International
, vol.54
, Issue.1
, pp. 99-109
-
-
Shimizu, T.1
Kuroda, T.2
Hata, S.3
Fukagawa, M.4
Margolin, S.B.5
Kurokawa, K.6
-
29
-
-
0031474029
-
Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy
-
T. Shimizu, M. Fukagawa, T. Kuroda, S. Hata, Y. Iwasaki, M. Nemoto, K. Shirai, S. Yamauchi, S.B. Margolin, F. Shimizu, and K. Kurokawa Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy Kidney Int. Suppl. 63 1997 S239 S243
-
(1997)
Kidney Int. Suppl.
, vol.63
-
-
Shimizu, T.1
Fukagawa, M.2
Kuroda, T.3
Hata, S.4
Iwasaki, Y.5
Nemoto, M.6
Shirai, K.7
Yamauchi, S.8
Margolin, S.B.9
Shimizu, F.10
Kurokawa, K.11
-
30
-
-
0029940563
-
Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis
-
I. Shirato, T. Sakai, K. Kimura, Y. Tomino, and W. Kriz Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis Am. J. Pathol. 148 1996 1283 1296 (Pubitemid 26111083)
-
(1996)
American Journal of Pathology
, vol.148
, Issue.4
, pp. 1283-1296
-
-
Shirato, I.1
Sakai, T.2
Kimura, K.3
Tomino, Y.4
Kriz, W.5
-
31
-
-
74149086684
-
Renoprotective properties of pirfenidone in subtotally nephrectomized rats
-
K. Takakura, A. Fujimori, T. Chikanishi, A. Tanokura, Y. Iwatsuki, M. Yamamoto, H. Nakajima, M. Okada, and H. Itoh Renoprotective properties of pirfenidone in subtotally nephrectomized rats Eur. J. Pharmacol. 629 2010 118 124
-
(2010)
Eur. J. Pharmacol.
, vol.629
, pp. 118-124
-
-
Takakura, K.1
Fujimori, A.2
Chikanishi, T.3
Tanokura, A.4
Iwatsuki, Y.5
Yamamoto, M.6
Nakajima, H.7
Okada, M.8
Itoh, H.9
-
32
-
-
84867700062
-
Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells
-
K. Takakura, A. Tahara, M. Sanagi, H. Itoh, and Y. Tomura Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells Ren. Fail. 34 2012 1309 1316
-
(2012)
Ren. Fail.
, vol.34
, pp. 1309-1316
-
-
Takakura, K.1
Tahara, A.2
Sanagi, M.3
Itoh, H.4
Tomura, Y.5
-
33
-
-
40449083921
-
Podocytes contribute to the formation of glomerular crescents
-
DOI 10.1681/ASN.2006101115
-
P.S. Thorner, M. Ho, V. Eremina, Y. Sado, and S. Quaggin Podocytes contribute to the formation of glomerular crescents J. Am. Soc. Nephrol. 19 2008 495 502 (Pubitemid 351355393)
-
(2008)
Journal of the American Society of Nephrology
, vol.19
, Issue.3
, pp. 495-502
-
-
Thorner, P.S.1
Ho, M.2
Eremina, V.3
Sado, Y.4
Quaggin, S.5
-
34
-
-
84868550831
-
Inhibitors/antagonists of TGF-β system in kidney fibrosis
-
M. Yanagita Inhibitors/antagonists of TGF-β system in kidney fibrosis Nephrol. Dial. Transplant 27 2012 3686 3691
-
(2012)
Nephrol. Dial. Transplant
, vol.27
, pp. 3686-3691
-
-
Yanagita, M.1
-
35
-
-
77955608255
-
Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis
-
C. Zhou, J. Wu, L. Torres, J.M. Hicks, T. Bartkowiak, K. Parker, and Y.H. Lou Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis Am. J. Nephrol. 32 2010 324 331
-
(2010)
Am. J. Nephrol.
, vol.32
, pp. 324-331
-
-
Zhou, C.1
Wu, J.2
Torres, L.3
Hicks, J.M.4
Bartkowiak, T.5
Parker, K.6
Lou, Y.H.7
|